---
document_datetime: 2024-02-23 14:24:52
document_pages: 13
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/fuzeon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: fuzeon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 21.3174251
conversion_datetime: 2025-12-28 11:26:09.466135
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Fuzeon

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0065              | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) | 16/10/2023                          |                                             | SmPC, Labelling and PL           |           |
| N/0064               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                          | 15/03/2023                          |                                             | PL                               |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0063            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                 | 22/11/2022   |     | SmPC, Labelling and PL   |                                   |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-----|--------------------------|-----------------------------------|
| IA/0062            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                  | 18/07/2022   | n/a |                          |                                   |
| N/0061             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                               | 04/11/2021   |     | PL                       |                                   |
| PSUSA/1217/ 202103 | Periodic Safety Update EU Single assessment - enfuvirtide                                                                                                                      | 28/10/2021   | n/a |                          | PRAC Recommendation - maintenance |
| N/0060             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                               | 10/08/2021   |     | PL                       |                                   |
| IA/0058            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                  | 21/10/2020   | n/a |                          |                                   |
| IA/0057/G          | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites | 10/10/2019   | n/a |                          |                                   |
| IB/0056            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                 | 27/08/2019   | n/a |                          |                                   |
| IB/0055            | B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting                                                                                            | 12/04/2019   | n/a |                          |                                   |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Addition of a new parameter to the specification with its test method                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            |      | specification corresponding   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-------------------------------|
| IA/0054/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.d.2.b - Change in test procedure for the finished product - Deletion of a test procedure if an | 09/01/2019 | n/a        |      | alternative method            |
| IAIN/0053 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                     | 11/10/2018 | 04/10/2019 | SmPC |                               |
| II/0051/G | This was an application for a group of variations. B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure Change in test procedure for AS or                                                                                                                   | 27/09/2018 | 04/10/2019 |      | B.I.b.2.a -                   |

<div style=\"page-break-after: always\"></div>

| starting material/reagent/intermediate changes to an approved B.I.b.2.a - Change in starting material/reagent/intermediate changes to an approved B.II.d.1.a - Change in and/or limits of the finished specification limits B.II.d.1.a - Change in and/or limits of the finished specification limits B.II.d.1.a - Change in and/or limits of the finished specification limits B.II.d.1.i - Change in and/or limits of the finished uniformity of dosage units the currently registered 2.9.5 or Ph. Eur. 2.9.6 B.II.d.1.z - Change in and/or limits of the finished B.II.d.1.z - Change in and/or limits of the finished B.II.d.1.z - Change in and/or limits of the finished B.II.d.2.a - Change in product - Minor changes procedure B.I.b.2.a - Change in starting material/reagent/intermediate   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| N/0052             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                | 09/08/2018   | 04/10/2019   | PL                     |                                                                                                                                           |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| T/0050             | Transfer of Marketing Authorisation                                                                                                                             | 20/02/2018   | 06/04/2018   | SmPC, Labelling and PL |                                                                                                                                           |
| PSUSA/1217/ 201603 | Periodic Safety Update EU Single assessment - enfuvirtide                                                                                                       | 29/09/2016   | n/a          |                        | PRAC Recommendation - maintenance                                                                                                         |
| IA/0049            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                   | 15/09/2016   | n/a          |                        |                                                                                                                                           |
| N/0048             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                | 09/08/2016   | 06/04/2018   | Labelling              |                                                                                                                                           |
| PSUSA/1217/ 201503 | Periodic Safety Update EU Single assessment - enfuvirtide                                                                                                       | 22/10/2015   | 16/12/2015   | SmPC and PL            | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1217/201503. |
| IG/0573            | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location | 01/07/2015   | n/a          |                        |                                                                                                                                           |
| IG/0497            | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location | 18/11/2014   | n/a          |                        |                                                                                                                                           |
| PSUV/0042          | Periodic Safety Update                                                                                                                                          | 09/10/2014   | n/a          |                        | PRAC Recommendation - maintenance                                                                                                         |

<div style=\"page-break-after: always\"></div>

| IB/0043   | B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products                                                                                                                                                                                                                                                                                                                                                                         | 05/08/2014   | n/a        |                                  |                                                                                                                                                                                                                                                                                       |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0041   | Update of section 4.8 of SmPC in line with the latest QRD template. PL has been updated accordingly. In addition, the warnings on the risk of transmission in SmPC section 4.4 and PL have been updated in line with class labelling request by the CHMP. Furthermore, the PL has been updated in line with the results of user testing, previously adopted recommendations for missed doses are included also in SmPC section 4.2 and the list of local representatives in the PL has been revised. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance | 20/03/2014   | 04/07/2014 | SmPC and PL                      | SmPC section 4.8 has been updated to align with the format in the latest QRD template, without changes to the content of the safety information presented. In addition, the Package Leaflet has been revised based on results of readability testing and comments raised by the CHMP. |
| IB/0039/G | This was an application for a group of variations. B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) C.I.7.a - Deletion of - a pharmaceutical form                                                                                                                                                                                                                                                                                                                                                                                                                            | 14/06/2013   | 04/07/2014 | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                                                                                                                       |
| IB/0038   | C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Changes with                                                                                                                                                                                                                                                                                                                                                                                                        | 28/05/2013   | 04/07/2014 | SmPC and PL                      |                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|         | NO new additional data are submitted by the MAH                                                                                                                                       |            |            |             |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IA/0040 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                         | 23/04/2013 | n/a        |             |
| IG/0228 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                        | 23/11/2012 | n/a        |             |
| N/0035  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                      | 29/10/2012 | 04/07/2014 | PL          |
| IG/0176 | A.4 - Administrative change - Change in the name and/or address of a manufacturer or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS | 25/06/2012 | n/a        |             |
| IA/0033 | B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place                   | 01/06/2012 | n/a        |             |
| II/0031 | Update of Summary of Product Characteristics and Package Leaflet                                                                                                                      | 18/03/2010 | 27/04/2010 | SmPC and PL |
| IB/0030 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                            | 22/12/2009 | n/a        | SmPC        |
| IB/0029 | IB_17_a_Change in re-test period of the active substance                                                                                                                              | 12/02/2009 | n/a        |             |
| IB/0028 | IB_10_Minor change in the manufacturing process of                                                                                                                                    | 06/02/2009 | n/a        |             |

<div style=\"page-break-after: always\"></div>

|         | the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |                                  |                                                                                                                                                                                                                                                                                            |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0027 | IA_09_Deletion of manufacturing site                                                                                                                                                                                                                                                                                                                                                                                                                      | 21/07/2008 | n/a        |                                  |                                                                                                                                                                                                                                                                                            |
| R/0026  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                   | 24/04/2008 | 08/07/2008 | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                                                                                                                            |
| II/0025 | Change in the manufacturer of the finished product. Quality changes                                                                                                                                                                                                                                                                                                                                                                                       | 13/12/2007 | 18/12/2007 |                                  |                                                                                                                                                                                                                                                                                            |
| II/0024 | Update of Summary of Product Characteristics and Package Leaflet To update section 5.2 of the SPC with information on enfuvirtide levels in the cerebrospinal fluid, following the CHMP request on 25 January 2007. Furthermore, the MAH took the opportunity of this variation to replace two images in the PL to better illustrate the handling of the protective cap of the syringes. Update of Summary of Product Characteristics and Package Leaflet | 20/09/2007 | 30/10/2007 | SmPC and PL                      | An investigator-initiated study evaluated the pharmacokinetics of enfuvirtide in the cerebrospinal fluid (CSF) of four HIV-infected patients. The results showed that the penetration of enfuvirtide in the CSF is negligible. This information has been included in the SPC.              |
| S/0023  | Annual re-assessment.                                                                                                                                                                                                                                                                                                                                                                                                                                     | 19/07/2007 | 02/10/2007 | Annex II                         |                                                                                                                                                                                                                                                                                            |
| II/0022 | Update of sections 4.2, 4.4 and 5.2 of the SPC with additional data in patients with reduced renal function in line with the CHMP conclusion in assessment of FUM 098.                                                                                                                                                                                                                                                                                    | 19/07/2007 | 30/08/2007 | SmPC                             | Following submission of a study to investigate Pharmacokinetics of Enfuvirtide in HIV-1 infected subjects with renal impairment, it was concluded that the effect of severe renal impairment on enfuvirtide pharmacokinetics is limited, although few subjects were included in the study. |

<div style=\"page-break-after: always\"></div>

|         | Update of Summary of Product Characteristics                                                                                                                                                                                                                                                                                                                                                                                |            |            |                                  | The study did not reveal any safety concerns. Compared to historical data, the exposure obtained in this study is similar to earlier study results. The small increase in exposure in patients with severe renal impairment or patients undergoing haemodialysis does not require dose adjustment. The information from this study on patients with reduced renal function has been included in the SPC.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0020 | Quality changes                                                                                                                                                                                                                                                                                                                                                                                                             | 21/06/2007 | 22/06/2007 |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IA/0021 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                                                                                                                                                                                                                                                           | 18/04/2007 | n/a        | Annex II and PL                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| II/0019 | Update of section 4.4 and section 4.8 of the SPC and section 2 of the PL to implement the class labelling text on osteonecrosis, agreed by the CHMP in September 2006. In addition the MAH completed the list of local representatives in the PL to include the two new EU Member States (Bulgaria and Romania) according to the latest EMEA/QRD template. Update of Summary of Product Characteristics and Package Leaflet | 14/12/2006 | 24/01/2007 | SmPC and PL                      | Cases of osteonecrosis (death of the bone tissue resulting from an insufficient blood supply) have been reported in HIV-infected patients since the end of the 80's. Although the cause of this disease could be due to multi factors (including the use of corticosteroids, alcohol consumption, severe immunosuppression, higher body mass index) it has occurred specially in patients with HIV advanced disease and/or in patients with long term use of combination antiretroviral therapy (CART). Further to the review of all available data the CHMP agreed that this information should now be included in the SPC and PL of all antiretroviral medicinal products. Patients should be warned to seek medical advice in case they experience joint stiffness, aches and pain especially of the hip, knee and shoulder or if they experienced any difficulty in movement. |
| II/0017 | Update of Summary of Product Characteristics, Annex II, Labelling and Package Leaflet                                                                                                                                                                                                                                                                                                                                       | 21/09/2006 | 24/10/2006 | SmPC, Annex II, Labelling and PL | The MAH has submitted this variation in order to amend section 4.4 and 5.3 of the SPC as requested by CHMP following the evaluation of the Specific Obligation 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

|         | To update sections 4.4 and 5.3 of the SPC as requested by CHMP following the evaluation of the Specific Obligation 1 concerning the immunotoxic potential of enfuvirtide . Furthermore, the MAH updated the product information according to the QRD template version 7. Update of Summary of Product Characteristics, Labelling and Package Leaflet   |            |            |                        | concerning the immunotoxic potential of enfuvirtide observed in animal models. Animal studies have shown that enfuvirtide may impair some immune functions.                                                                                                                                                  |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| S/0018  | Annual re-assessment.                                                                                                                                                                                                                                                                                                                                  | 27/07/2006 | 21/09/2006 | Annex II               |                                                                                                                                                                                                                                                                                                              |
| IA/0015 | IA_01_Change in the name and/or address of the marketing authorisation holder                                                                                                                                                                                                                                                                          | 14/12/2005 | n/a        | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                              |
| IA/0014 | IA_43_a_01_ Add./replacement/del. of measuring or administration device - addition or replacement                                                                                                                                                                                                                                                      | 14/12/2005 | n/a        | PL                     |                                                                                                                                                                                                                                                                                                              |
| IA/0016 | IA_09_Deletion of manufacturing site                                                                                                                                                                                                                                                                                                                   | 09/12/2005 | n/a        |                        |                                                                                                                                                                                                                                                                                                              |
| S/0013  | Annual re-assessment.                                                                                                                                                                                                                                                                                                                                  | 28/07/2005 | 05/10/2005 | Annex II               | The CHMP reviewed the evidence of compliance with the specific obligations (SOBs) and reassessed the benefit- risk profile of the medicinal product. Some SOBs and follow-up measures remain unresolved. Therefore the CHMP agreed that the Marketing Authorisation remains under exceptional circumstances. |
| II/0012 | Quality changes                                                                                                                                                                                                                                                                                                                                        | 17/02/2005 | 11/04/2005 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

| II/0009   | Quality changes                                                                                                                                               | 16/03/2005   | 22/03/2005   |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0008   | Change(s) to the test method(s) and/or specifications for the active substance Change(s) to the test method(s) and/or specifications for the finished product | 16/03/2005   | 20/03/2005   |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| II/0011   | Update of Summary of Product Characteristics and Package Leaflet                                                                                              | 18/11/2004   | 17/12/2004   | SmPC and PL | In patients treated with any type of combination antiretroviral therapy (CART), an inflammatory response to indolent or residual opportunistic infections may occur, when the immune system responds to treatment. In most cases, the inflammatory reactions towards the opportunistic pathogens in question cannot be foreseen since the opportunistic infection has not yet been detected/ diagnosed. if diagnosed prior to institution of CART, the treatment against the opportunistic infection (OI) is usually given priority. In particular, this is true for the complications most feared in this context; CMV-retinitis, generalised mycobacterial infectionsand Pneumocystis carinii pneumonia. An additional reason for treating the OI and the HIV-infection sequentially, is the great risk of adverse events (toxicity or lack of effect) due to drug interactions. in conclusion, in most cases, the clinical consequences of the awakening immune system in patients starting ART cannot be prevented. therefore, early recognition and diagnosis of these inflammatory reactions are important in the clinical handling of the patient. the description and the guidelines for treatment of the |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                |            |            |             | ssociation with the reactivation of the immune system in HIV-infected patients are given in the textbooks of infectious diseases. Hwever, as the clinical conditions associated with the reactivation of the immune system may constitute a threat to the patient, a reminder of the phenomenon is deemed of value and has been included in the SPC and PL of all antiretroviral medicinal products.   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0010 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                     | 02/12/2004 | n/a        | SmPC        |                                                                                                                                                                                                                                                                                                                                                                                                        |
| S/0006  | Annual re-assessment.                                                                                                                          | 29/07/2004 | 15/10/2004 | Annex II    |                                                                                                                                                                                                                                                                                                                                                                                                        |
| IA/0007 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                              | 21/09/2004 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                        |
| II/0005 | Update of Summary of Product Characteristics and Package Leaflet                                                                               | 22/04/2004 | 08/06/2004 | SmPC and PL |                                                                                                                                                                                                                                                                                                                                                                                                        |
| II/0002 | Change(s) to the manufacturing process for the finished product Change(s) to the test method(s) and/or specifications for the active substance | 24/03/2004 | 31/03/2004 |             |                                                                                                                                                                                                                                                                                                                                                                                                        |
| IA/0004 | IA_43_a_01_ Add./replacement/del. of measuring or administration device - addition or replacement                                              | 02/02/2004 | n/a        | PL          |                                                                                                                                                                                                                                                                                                                                                                                                        |
| IA/0003 | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                                                 | 27/01/2004 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                        |
| I/0001  | 12_Minor change of manufacturing process of the active substance                                                                               | 21/07/2003 | 30/07/2003 |             |                                                                                                                                                                                                                                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

<!-- image -->